205 related articles for article (PubMed ID: 16308732)
1. EDB fibronectin and angiogenesis -- a novel mechanistic pathway.
Khan ZA; Chan BM; Uniyal S; Barbin YP; Farhangkhoee H; Chen S; Chakrabarti S
Angiogenesis; 2005; 8(3):183-96. PubMed ID: 16308732
[TBL] [Abstract][Full Text] [Related]
2. Glucose-induced serum- and glucocorticoid-regulated kinase activation in oncofetal fibronectin expression.
Khan ZA; Barbin YP; Farhangkhoee H; Beier N; Scholz W; Chakrabarti S
Biochem Biophys Res Commun; 2005 Apr; 329(1):275-80. PubMed ID: 15721303
[TBL] [Abstract][Full Text] [Related]
3. Endothelins: regulators of extracellular matrix protein production in diabetes.
Khan ZA; Farhangkhoee H; Mahon JL; Bere L; Gonder JR; Chan BM; Uniyal S; Chakrabarti S
Exp Biol Med (Maywood); 2006 Jun; 231(6):1022-9. PubMed ID: 16741042
[TBL] [Abstract][Full Text] [Related]
4. Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice.
Coltrini D; Ronca R; Belleri M; Zardi L; Indraccolo S; Scarlato V; Giavazzi R; Presta M
J Pathol; 2009 Dec; 219(4):455-62. PubMed ID: 19824060
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of transforming growth factor-beta1 and vascular endothelial growth factor in cultured keloid fibroblasts: relevance to angiogenic activity.
Fujiwara M; Muragaki Y; Ooshima A
Arch Dermatol Res; 2005 Oct; 297(4):161-9. PubMed ID: 16184401
[TBL] [Abstract][Full Text] [Related]
6. C-peptide and retinal microangiopathy in diabetes.
Chakrabarti S; Khan ZA; Cukiernik M; Zhang W; Sima AA
Exp Diabesity Res; 2004; 5(1):91-6. PubMed ID: 15198374
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.
Chen S; Feng B; George B; Chakrabarti R; Chen M; Chakrabarti S
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E127-37. PubMed ID: 19903865
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta1 (TGF-beta1) regulates ATDC5 chondrogenic differentiation and fibronectin isoform expression.
Han F; Adams CS; Tao Z; Williams CJ; Zaka R; Tuan RS; Norton PA; Hickok NJ
J Cell Biochem; 2005 Jul; 95(4):750-62. PubMed ID: 15832361
[TBL] [Abstract][Full Text] [Related]
9. Sphingosylphosphorylcholine stimulates expression of fibronectin through TGF-beta1-Smad-dependent mechanism in human mesenchymal stem cells.
Moon HJ; Jeon ES; Kim YM; Lee MJ; Oh CK; Kim JH
Int J Biochem Cell Biol; 2007; 39(6):1224-34. PubMed ID: 17481939
[TBL] [Abstract][Full Text] [Related]
10. Endothelin-mediated remodeling in aortas of diabetic rats.
Fukuda G; Khan ZA; Barbin YP; Farhangkhoee H; Tilton RG; Chakrabarti S
Diabetes Metab Res Rev; 2005; 21(4):367-75. PubMed ID: 15580650
[TBL] [Abstract][Full Text] [Related]
11. Regulation of vascular endothelial growth factor expression by extra domain B segment of fibronectin in endothelial cells.
Chen S; Chakrabarti R; Keats EC; Chen M; Chakrabarti S; Khan ZA
Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8333-43. PubMed ID: 23150625
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
13. Critical effect of VEGF in the process of endothelial cell apoptosis induced by high glucose.
Yang Z; Mo X; Gong Q; Pan Q; Yang X; Cai W; Li C; Ma JX; He Y; Gao G
Apoptosis; 2008 Nov; 13(11):1331-43. PubMed ID: 18780185
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
Siddiqui I; Khan ZA; Lian D; Jiang J; Zhong R; Garcia B; Chakrabarti S
Transplantation; 2006 Aug; 82(3):406-14. PubMed ID: 16906041
[TBL] [Abstract][Full Text] [Related]
15. Signaling by ALK5 mediates TGF-beta-induced ET-1 expression in endothelial cells: a role for migration and proliferation.
Castañares C; Redondo-Horcajo M; Magán-Marchal N; ten Dijke P; Lamas S; Rodríguez-Pascual F
J Cell Sci; 2007 Apr; 120(Pt 7):1256-66. PubMed ID: 17376964
[TBL] [Abstract][Full Text] [Related]
16. Effect of magnolol on TGF-beta1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions.
Kim YS; Jung DH; Kim NH; Lee YM; Kim JS
Eur J Pharmacol; 2007 May; 562(1-2):12-9. PubMed ID: 17321517
[TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
18. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
[TBL] [Abstract][Full Text] [Related]
19. [Effects of aldosterone on synthesis of fibronectin and expression of transforming growth factor-beta1 mRNA in cultured rat mesangial cells].
Li XD; Chen XW; Tang DS; Liang D; Liu HF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):140-2. PubMed ID: 17286908
[TBL] [Abstract][Full Text] [Related]
20. Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy.
Nakagawa T; Sato W; Sautin YY; Glushakova O; Croker B; Atkinson MA; Tisher CC; Johnson RJ
J Am Soc Nephrol; 2006 Mar; 17(3):736-45. PubMed ID: 16436494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]